Expression level of metastasis-associated protein 1 (MTA1) is closely related to tumor growth and metastasis in various cancers. Although increased expression level of MTA1 was observed in hepatocellular carcinoma (HCC), role of MTA1 complex containing histone deacetylase (HDAC) in hepatitis B virus (HBV)-associated hepatocarcinogenesis has not been studied. Here, we demonstrated that HBx strongly induced the expression of MTA1 and HDAC1 genes at transcription level. MTA1 and HDAC1/2 physically associated with hypoxia-inducible factor-1a (HIF-1a) in vivo in the presence of HBx, which was abolished by knockdown of MTA1 by short interfering RNA (siRNA). HBx induced deacetylation of the oxygen-dependent degradation domain of HIF-1a, which was accompanied with dissociation of prolyl hydroxylases and von Hippel-Lindau tumor suppressor from HIF-1a. These results indicate that HBx-induced deacetylation is important for proteasomal degradation of HIF-1a. Further, we observed that protein levels of MTA1 and HDAC1 were increased in the liver of HBxtransgenic mice. Also, there was a higher expression of HDAC1 in HCC than in the adjacent non-tumorous cirrhotic nodules in 10 out of 12 human HBV-associated HCC specimens. Together, our data indicate a positive cross talk between HBx and the MTA1/HDAC complex in stabilizing HIF-1a, which may play a critical role in angiogenesis and metastasis of HBV-associated HCC.
Introduction
Hepatitis B virus (HBV) infection is the major risk factors for the development of hepatocellular carcinoma (HCC), one of the most prevalent malignant diseases worldwide (Cougot et al., 2005) . HBV has a circular, partially double-stranded DNA genome that consists of four overlapping open reading frames encoding DNA polymerase, HBV surface protein, HBV core protein and a regulatory X protein, HBx. Among these, HBx has been the focus of much attention because it is strongly implicated in hepatocarcinogenesis (Murakami 2001; Zhang et al., 2006) . Forced expression of HBx protein enhanced the survival and proliferative potential of liver cells, whereas knockdown of HBx gene reduces the tumorigenicity of HCC cells (Yun et al., 2002; Chan and Ng, 2006) . Further, exogenous HBx expression has been linked to the induction of liver tumors in transgenic (TG) mice (Kim et al., 1991; Yu et al., 1999; Wu et al., 2006) . Hepatocellular carcinoma cells frequently show early invasion into blood vessels as well as formation of intrahepatic metastases (Kondo and Wada, 1991) . Later extrahepatic metastases also occur in tissues such as the brain, which are not endemic HBV infections (Frati et al., 2002) . HBx has been strongly implicated in angiogenesis and metastasis during development of the aggressive behavior of HCC cells. HBx induces adherens junction disruption and integrin-mediated adhesion to the extracellular matrix (Lara-Pezzi et al., 2001a, b) . It promotes the expression of membrane-type matrix metalloproteinase-1, -3 and -9, and thereby enhances the invasive potential of the HCC cells expressing HBx (Lara-Pezzi et al., 2002 , Chung et al., 2004 Yu et al., 2005; Ou et al., 2006) . We and others have demonstrated that HBx increased the expression level of vascular endothelial growth factor, a strong angiogenic factor, through enhancing the transcriptional activity of hypoxia-inducible factor-1a (HIF-1a) (Yoo et al., 2003 (Yoo et al., , 2004 Moon et al., 2004a) . HIF-1a is an oxygen-regulated subunit of HIF-1, a key regulator of cellular adaptive responses to hypoxia, including many pathways that are important for tumor growth and metastasis (Maxwell, 2005) . Hydroxylation of two specific proline residues Pro402 and Pro564 in the oxygen-dependent degradation (ODD) domain of HIF1a promotes interactions with von Hippel-Lindau (VHL) tumor-suppressor protein that targets HIF-1a for ubiquitin-mediated proteolysis. Specific prolyl hydroxylases (PHDs) catalyse the hydroxylation of these proline residues in an oxygen-dependent manner (Brahimi-Horn et al., 2005) . Recent investigations suggest that acetyltransferases and histone deacetylases (HDACs) may have a role in the regulation of stability and transcriptional activity of HIF-1a (Jeong et al., 2002; Chang et al., 2006; Yoo et al., 2006) .
Metastasis-associated protein 1 (MTA1) has been regarded as a candidate metastasis-associated gene that plays an important role in tumor invasiveness and metastasis, since the rat mta1 gene was identified in a highly metastatic mammary adenocarcinoma cell line using a differential cDNA library screening (Toh et al., 1994) . MTA1 is normally present only at low levels in various tissues, but there are elevated MTA1 levels in a variety of tumor types such as breast, colorectal, gastric and esophageal carcinomas (Toh et al., 1999; Kumar et al., 2003; Nicolson et al., 2003) . In the case of hepatomas, MTA1 levels in HCC are significantly higher than that in non-malignant hepatocytes. MTA1 expression level is well correlated with vascular invasion, in that 95% of HCC specimens with vascular invasion displayed strong MTA1 level (Moon et al., 2004b) . The disease-free survival rate for patients with high levels of MTA1 was significantly less than for those with low levels, although there were no correlations between MTA1 level and cancer invasion to the portal vein, or intrahepatic metastasis in that investigation (Hamatsu et al., 2003) . Thus, a high expression level of MTA1 may indicate the potential aggressiveness as well as prognosis of HCC.
Recently, we showed that MTA1 induces deacetylation of HIF-1a in association with HDAC1, and thereby enhances the stability and transcriptional function of HIF-1a (Yoo et al., 2006) . This finding suggests a possible link between the metastatic potential of HBx and the prevalent expression of MTA1 and HIF-1a in the progressive phenotype of HCC cells. Here we studied the function of HBx in invasive and metastatic changes during HBV-mediated hepatocarcinogenesis in association with MTA1 and HDAC1.
Results
HBx induces the expression of MTA1 and HDAC1 at the transcription level We first examined whether HBx regulates the expression level of MTA1 using the Chang X-34 cell line, in which expression of the HBx gene is under control of an inducible doxycycline promoter (Yun et al., 2002; Yoo et al., 2003) . Expression levels of MTA1 and HDAC1 proteins were increased dramatically when the cells expressed the HBx gene after doxycycline treatment (Figure 1a ). Consistent with our previous finding, the level of HIF-1a protein was increased in the presence of HBx (Yoo et al., 2003) . To further confirm this, we introduced an HBx gene-expressing plasmid into the human HCC cell line HepG2, and into a non-hepatic origin NIH3T3. In both cell lines, the expression levels of MTA1 and HDAC1 proteins were increased in the presence of HBx, which was similar to their induction under hypoxia (Figure 1b) . The mRNA levels of MTA1 and HDAC1 were increased, although the mRNA level of HIF-1a was unchanged in the presence of HBx or desferrioxamin, a hypoxia-mimicking agent, indicating that HBx induces the expression of MTA1 and HDAC1 genes at the transcription level (Figure 1c ).
MTA1 and HDAC1 are involved in the stabilization of HIF-1a that is induced by HBx Next, we examined whether the HBx-induced MTA1 and HDAC1 might play a role in stabilization of HIF1a. We used short interfering RNA (siRNA) duplexes targeting MTA1 (si-MTA1) or HDAC1. The MTA1 protein was not detected when three different types of si-MTA1 were introduced into doxycycline-treated Chang X-34 cells. The protein level of HIF-1a was significantly decreased in the presence of all three si-MTA1s ( Figure 2a ). Similarly, the protein level of HIF-1a that was increased by either introducing HBx or exposing to hypoxia in HepG2, was abolished when si-MTA1s were transfected ( Figure 2b ). We also observed that when HDAC1 or HDAC2 protein level was suppressed by DNA vector-based RNA interference, the HBx-induced HIF-1a protein level was decreased ( Figure 2c ). When
HepG2 cells were treated with cycloheximide, which blocks de novo protein synthesis, most of the ODD domain of HIF-1a fused with glutathione-S-transferase (GST), that is, GST-ODD, was degraded within 5 min under normoxia, but the integrity of the protein was maintained in the presence of HBx for up to 60 min. The HBx-induced integrity of GST-ODD decreased after 5 min of cycloheximide treatment in the presence of an HDAC inhibitor, trichostatin A (TSA) (Figure 2d ). Together these results indicate that the induction of both MTA1 and HDAC1 gene expression is required for the HBx-induced stabilization of HIF-1a.
HIF-1a was deacetylated in the presence of HBx
To further characterize the cross talk between MTA1/ HDAC1 and HBx, we examined whether these proteins were physically associated with HIF-1a. First, we observed that HIF-1a, MTA1 and HDAC1 were localized in the nucleus in the presence of HBx ( Figure 3a ). Next, HIF-1a coprecipitated efficiently with MTA1, HDAC1 and HDAC2 in the presence of HBx ( Figure 3b ). Further, we checked whether MTA1 is required for the binding of HDAC1/2 with HIF-1a and HBx. HIF-1a associated with HBx in the presence or absence of MTA1; however, it did not interact with HDAC1/2 in the absence of MTA1 ( Figure 3c ). Together, these results indicate that MTA1 expression as well as its interaction with HIF-1a is necessary for the HBx-mediated stabilization HIF-1a. ) was added into the media for the last 3 h of the incubation. At the end of incubation, 10 mM cycloheximide was added for the indicated time periods. Expression of the indicated proteins was analysed by western blot analysis. One representative of at least three independent experiments with similar results is shown. GST, glutathione-S-transferase; HBx, HBV regulatory protein; HDAC1, histone deacetylase1; HIF-1a, hypoxia-inducible factor-1a; MTA1, metastasis-associated protein 1; ODD, oxygen-dependent degradation; siRNA, short interfering RNA; TSA, trichostatin A.
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Next, we tested whether HIF-1a was deacetylated when HIF-1a was stabilized by HBx, since HDAC-induced deacetylation was proposed as one of the mechanisms involved in the stabilization of HIF-1a (Yoo et al., 2006) . We examined acetylation of HIF-1a using two different antibodies, that is, anti-pan-Ac or anti-acetylated lysine antibodies. Acetylated HIF-1a was reciprocally immunoprecipitated by both acetylation-detecting antibodies and FLAG-tagged HIF-1a (Figure 4a ). We confirmed that HIF-1a was acetylated under normoxia when degradation of HIF-1a was blocked by treatment with MG132, an inhibitor of proteasome activity. In contrast, the level of acetylated HIF-1a was undetectable when the integrity of HIF-1a was maintained in the presence of HBx (Figure 4b) . When the acetylation level of the GST-fused ODD domain was examined, the level of acetylation was decreased in the presence of HBx, suggesting that the ODD domain may contain deacetylating site for the HBx-induced MTA1/HDAC1 complex (Figure 4c ). Although protein level of wild-type (WT) HIF-1a was increased by HBx expression, the expression of K532R, a mutant with a point mutation at the acetylating lysine residue, was not altered under these conditions. TSA treatment decreased the level of WT HIF-1a but not K532R (Figure 4d ). These results suggest that acetylation/deacetylation of HIF-1a may be one of critical targets for the HBx-induced stabilization of HIF-1a.
We further investigated whether HBx affected the binding of PHD to HIF-1a ODD domain. PHDs bound strongly to HIF-1a in the presence of MG132 under normoxia; however, the binding was largely decreased in the presence of HBx (Figure 5a ). TSA treatment recovered the binding of PHD2 to HIF-1a ODD, indicating that HDAC activity is involved in this process (data not shown). The VHL protein bound strongly to the HIF-1a ODD domain when the acetylated HIF-1a was present in the presence of MG132; however, the binding was completely abolished in the presence of HBx (Figure 5b ). Together, these results indicate further that HBx-induced HDAC function is important for the regulation of acetylation, prolyl hydroxylation and ubiquitination/proteasomal degradation of HIF-1a.
Expression of MTA1 and HDAC1 is increased in liver samples of HBx-expressing TG mice and HCC patients We examined the expression of HDAC1 and MTA1 in liver samples obtained from HBx-TG mice. The levels of MTA1, HDAC1 and HIF-1a proteins were increased through all the experimental ages of the HBx-TG mice liver samples to compare with the age-matched WT control mice (Figure 6a ). By immunohistochemistry, we found that HDAC1 proteins were strongly stained in the nucleus in the hepatocytes of the HBx-TG mice, but not in the WT control mice (Figure 6b ). Finally, the expression level of HDAC1 was assessed in the HBVassociated HCC specimens. In 10 out of 12 HBV-positive HCC specimens, there was a higher level of HDAC1 in the HCC cells than in the adjacent non-tumorous cirrhotic nodules (Figure 7) . Immunoreactivity for 2 and 4) . A 500-mg weight whole-cell lysates was IP with HIF-1a antibodies, and then analysed by WB analysis. Expression of indicated proteins was analysed by WB analysis as control. One representative of at least three independent experiments with similar results is shown. HBx, HBV regulatory protein; HDAC1, histone deacetylase1; HIF-1a, hypoxia-inducible factor-1a; MTA1, metastasis-associated protein 1; si-MTA1, siRNA duplexes targeting MTA1.
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Y-G Yoo et al HDAC1 in HCC was observed strongly in the nucleus but very weakly in cytoplasm. The bile duct epithelium and some inflammatory cells always showed nuclear immunoreactivity and served as an internal control for positive staining (data not shown). Taken together, our results demonstrated that the expression levels of both MTA1 and HDAC1 are increased in the presence of HBx, which may induce the expression of HIF-1a associated with angiogenesis and metastasis in HBVassociated hepatomas.
Discussion
Hepatocellular carcinomas have high rates of intrahepatic invasion and metastasis, which are the major causes of treatment failure and death among cancer patients. The HBV viral transactivator, HBx, has been strongly implicated in angiogenesis and metastasis during aggressive progression of the HCCs. Here, we showed that HBx strongly induced the expression of MTA1 and HDAC1, and thereby enhanced the stability of HIF-1a, suggesting that these proteins may mediate, at least partly, the metastatic function of the HBx. Previous immunohistochemical studies showed that the levels of MTA1 were significantly higher in HCC cells than in non-malignant hepatocytes and this is well correlated with vascular invasion (Moon et al., 2004b) . Similarly, the expression levels of HIF-1a and vascular endothelial growth factor, and microvessel densities, are all significantly higher in HCC tumors than in paraneoplastic and normal liver tissue (Huang et al., 2005) . The disease-free survival time of patients with high HIF-1a expression is significantly shorter than among those with the low expression (Wada et al., 2006) . Because metastasis is one of the most important factors affecting prognosis, expression levels of MTA1/ HDAC1 proteins may serve as prognostic markers for HCC treatments such as hepatectomy and chemotherapy. Although roles of HDACs and HDAC inhibitors in the regulation of HIF-1a have been suggested (Kim 2 culture dishes and incubated overnight. Cells were transfected with 6 mg expression vector encoding FLAG-HIF-1a and continually incubated for 24 h. The cells were treated with 20 mM MG132 for 2 h before being harvested. The expression of FLAG-HIF-1a and a-tubulin in whole-cell lysates was analysed by western blotting as control (upper). A 1000-mg weight of whole-cell lysates was immunoprecipitated (IP) with 2 mg each the indicated antibody, and then probed using anti-FLAG, anti-pan-Ac and anti-acetylated lysine antibodies (middle and lower blots). (b) HepG2 cells were transfected with 6 mg expression vector encoding FLAG-HBx, or empty vector and continually incubated for 24 h. The cells were treated with 10 mM MG132 for 1 h before being harvested. A 500-mg weight of whole-cell lysates was immunoprecipitated with 1 mg anti-pan-Ac antibody, and then probed using anti-HIF-1a antibody by western blot analysis. The expression of the indicated proteins was analysed by western blot analysis as control. (c) NIH3T3 cells were transfected with 3 mg each GST-ODD, FLAG-HBx and/or empty vector, and continually incubated for 24 h. A 500-mg weight of whole-cell lysates was IP with 1 mg anti-pan-Ac antibody, and then probed using anti-GST antibody by western blot analysis. The expression of the indicated proteins was analysed by western blot analysis as control. (d) Human embryonic kidney293 cells were transfected with 1 mg each expression vector for WT FLAG-HIF-1a or K532R mutant (K532R), together with 3 mg each of Myc-HBx, or empty vector, and continually incubated for 24 h. At the end of incubation, 300 ng ml À1 TSA was added for 3 h as indicated. Expression of FLAG-HIF-1a, Myc-HBx and a-tubulin was analysed by western blot analysis. One representative of at least three independent experiments with similar results is shown. GST, glutathione-S-transferase; HBx, HBV regulatory protein; HIF-1a, hypoxia-inducible factor-1a; ODD, oxygen-dependent degradation; WT, wild type. Jeong et al., 2002; Qian et al., 2006) , the acetylation hypothesis remains controversial since human ARD1 does not, at least directly, acetylate HIF1a (Arnesen et al., 2005; Bilton et al., 2005 Bilton et al., , 2006 Fisher et al., 2005; Murray-Rust et al., 2006) . Instead, diverse other mechanisms have been proposed for the HDAC inhibitor-induced HIF-1 regulation; Kong et al. (2006) showed that HDAC inhibitors induced the proteasomal degradation of HIF-1a by interacting with HSP70 and thereby disrupted the HSP70/HSP90 axis function. In the other hand, Fath et al. (2006) reported that acetylation regulated HIF-1 function by targeting the HIF-1a/p300 complex, not by directly targeting HIF-1a. Here, we showed that the ODD domain of HIF-1a was deacetylated in the presence of HBx (Figure 4) , and the deacetylation was accompanied by further process of proteasomal degradation, such as binding to PHDs and VHL ( Figure 5 ). These results strongly support that acetylation of HIF-1a is one of important mechanisms in HIF-1 regulation. Elucidation of the roles of acetylation such as protein stability and transactivation function of HIF-1a, acetylating sites in each functional domain, catalysing enzymes and their cross-talk with other proteins such as HBx and MTA1, would facilitate the understanding of HIF-1 regulation at the molecular level as well as its application to hypoxia-associated human diseases.
Recently, post-translational modification of nonhistone proteins by acetylation/deacetylation has been considered as a major regulatory event that controls ubiquitination/proteasomal degradation, intracellular trafficking, microtubule dynamics and subcellular localization of various proteins (Glozak et al., 2005; Minucci and Pelicci, 2006) . Our study showed for the first time that deacetylation of HIF-1a is associated with HBx function, suggesting that there may be other proteins for which acetylation/deacetylation status are modified by HBx. HBx interacts with and modulates the function of p53, Rb and E2F, the activities of which are regulated by acetylation and deacetylation (Minucci and Pelicci, 2006) . Therefore, MTA1/HDAC may mediate, at least in part, HBx function by affecting the acetylation/ At the end of incubation, the cells were treated with or without 10 mM MG132 for 1 h. (b) NIH3T3 cells were transfected with the indicated combinations of 2 mg of GST-ODD, 3 mg each of Myc-VHL, FLAG-HBx or empty vector. After 3 h of transfection, the cells were incubated under hypoxia or normoxia for 24 h as indicated. A 500-mg weight of whole-cell lysates was immunoprecipitated (IP) and then probed using specific antibodies as indicated. The expression of protein was analysed by western blot (WB) analysis as control. One representative of at least three independent experiments with similar results is shown. GST, glutathione-S-transferase; HBx, HBV regulatory protein; HIF-1a, hypoxia-inducible factor-1a; ODD, oxygen-dependent degradation; PHD, prolyl hydroxylase. Figure 6 The expression of HIF-1a, MTA1, and HDAC1 was increased in the liver of HBx-TG mice. (a) Western blot analysis was performed to monitor expression of protein in whole cell lysates obtained from liver tissues of the indicated aged C57BL/6 WT and HBx-TG mice. One representative experiment of at least three independent experiments with similar results is shown. (b) Immunohistochemical staining of HDAC1 in the liver sections from WT (upper), 9-month-and 13-month-old HBx-TG mice (lower). Original magnification, Â 400. HBx, HBV regulatory protein; HDAC1, histone deacetylase1; HIF-1a, hypoxia-inducible factor-1a; MTA1, metastasis-associated protein 1; TG, transgenic; WT, wild type. deacetylation status of these regulatory factors. Indeed, various viral proteins such as E6 and E7 of the papilloma virus, Tax of the human T-cell leukemia virus and EBNA2 of the Epstein-Barr virus interact with histone acetyltransferases and HDACs, and frequently use these enzymes to modify the normal cellular acetylation signaling (Caron et al., 2002) . This may indicate that cellular acetylation signaling could be one of the important and common targets, providing advantages for the life cycle of these pathogenic viruses. Whether viruses encoding these viral oncogenes utilize post-translational modifications for HIF-1a to take advantage in tumor progression, needs for further investigation.
During the last decade, HDACs have been considered to be among the most promising targets in drug development for treating various human cancers, including HCC. Currently, the first-generation HDAC inhibitors are being tested in phase I and phase II clinical trials (Armeanu et al., 2005; Minucci and Pelicci, 2006; Pathil et al., 2006) . Because many malignant diseases share an epigenetic etiology, modulation of chromatin remodeling by HDAC inhibitors has been suggested as an important epigenetic mechanism for cancer therapy. However, given the pleiotropic effects of HDACs on non-histone substrates, additional targets of HDAC inhibitors are expected. Here, our results provide the first indication that the tight association between HBx and the MTA1/HDAC complex contributes mechanistically to the induction of liver cancer metastasis through the activation of HIF-1a and vascular endothelial growth factor. Clinicopathological studies have consistently revealed that the levels of HIF-1a, vascular endothelial growth factor and MTA1/HDAC1 in HCC tissues are significantly higher than those in paraneoplastic and normal liver tissues. Thus, we proposed that the HIF-1a stabilization induced by HBx through activation of MTA1/HDAC1, might provide a distinct and important non-epigenetic mechanism for the antitumor activity of HDAC inhibitors against the HBV-associated HCC. Moreover, the results obtained here may open up promising new approaches for treatment of this malignancy.
Materials and methods
Cell culture and hypoxic treatment Chang and Chang X-34 cells, in which HBx gene expression is under the control of a doxycycline-inducible promoter, were described previously (Yun et al., 2002; Yoo et al., 2003) . HepG2, HeLa, human embryonic kidney 293 and NIH3T3 cells were obtained from the American Type Culture Collection. Cells were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum or calf serum at 37 1C in a 5% CO 2 /95% air incubator. Cells were exposed to hypoxia (0.1% O 2 ) by incubation at 37 1C in a 5% CO 2 /10% H 2 /85% N 2 anerobic incubator (Forma Scientific, Waltham, MA, USA). Hypoxia was also induced chemically by treating cells with 100 mM desferrioxamin.
Western blot analysis and immunoprecipitation
Whole-cell lysates were obtained and western blot was performed as previously described (Yoo et al., 2003 (Yoo et al., , 2006 ) using specific antibodies against HIF-1a, MTA1, HDAC1, HDAC2, VHL, hemagglutinin, Myc, YY1 and green-fluorescent protein (GFP) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), FLAG (Sigma, St Louis, MO, USA), GST (Amersham Pharmacia, Piscataway, NJ, USA), or a-tubulin (Oncogene, Boston, MA, USA). Immunoprecipitation was performed as previously described (Yoo et al., 2006) . To detect the acetylated HIF-1a, cell lysates were immunoprecipitated and proved with various combinations of anti-pan-Ac (Santa Cruz Biotechnology), antiacetylated lysine (Cell Singnaling, Danvers, MA, USA), anti-FLAG, anti-GST and anti-HIF-1a antibodies. Subcellular fractionation and immunoprecipitation were performed as previously described (Yoo et al., 2005 (Yoo et al., , 2006 .
Plasmids and transient transfection
The eukaryotic expression vectors for pCMV-Myc-HBx, pEBG-ODD (GST-fused ODD domain, amino acids 401B603, of HIF-1a, GST-ODD), p3XFLAG7.1-HIF-1a (WT), p3XFLAG7.1-HIF-1a K532R (K532R), pCMV-Myc-VHL and pEGFP-N1-PHD1-3 were described previously (Yoo et al., 2003 (Yoo et al., , 2006 . The pCMV-FLAG-HDAC1, pCS4-3Myc-HDAC2 plasmids were kindly provided by Drs Tso-Pang Yao and Suk-Chul Bae, respectively. The p3XFLAG7.1-HBx was constructed by inserting the full-length HBx into p3XFLAG7.1 vector (Sigma). Transient transfection was performed as described previously (Yoo et al., 2006) .
Transfection of siRNA
Transfection of si-MTA1 and the nonspecific control siRNA, si-GL3, were as described previously (Mishra et al., 2003) . The pBS/U6 empty vector, si-C, and the plasmids bearing the siRNA targeting HDAC1 (pBS/U6-HDAC1) and HDAC2 (pBS/U6-HDAC2) were kindly gifted by Dr Edward Seto.
Reverse transcriptase-and quantitative real-time PCR Reverse transcriptase-polymerase chain reaction was performed with primers specific for MTA1, HIF-1a, HBx, b-actin and HDAC1 as previously described (Yoo et al., 2003 (Yoo et al., , 2003 (Yoo et al., , 2006 . Quantitative real-time PCR amplifications were performed using Fast Start DNA Master SYBR Green I Mixture Kit (Roche Diagnostics, Basel, Switzerland) in a Light Cycler system (Roche Diagnostics). To determine the specificity of amplification, melting-curve analysis was applied to all final PCR products. The Cp value was normalized to that of b-actin and expressed as fold induction relative to vehicle treatment.
Animals, tumor samples and immunohistochemistry
We used the HBx homozygote TG mice at different ages and age-matched C57BL/6 WT mice (Yu et al., 1999; Yoo et al., 2003) . The experimental protocol was approved by the Committee for Care and Use of Laboratory Animals at Seoul National University, according to the Guide for Animal Experiments edited by Korean Academy for Medical Sciences. Mice were killed under ether anesthesia, and the liver was removed and a part of the liver was frozen at À70 1C. Wholecell lysates obtained from the frozen liver sections were used for western blot analysis. A standard immunohistochemical analysis was performed to visualize the expression of HDAC1, as described previously (Yoo et al., 2003) . A mouse anti-human HDAC1 antibody (1:300 dilution; Santa Cruz Biotechnology) was used as primary antibody.
Twelve patients with HBV-associated HCC were retrospectively identified from the surgical pathology files of the Department of Pathology at Samsung Medical Center, and their archival tissues were obtained. All samples were collected anonymously according to Institutional Review Board guidelines. All patients had undergone a surgical operation and had received neither chemotherapy nor radiotherapy before surgical resection. Immunohistochemical analysis was performed as described previously using rabbit anti-HDAC1 polyclonal antibody (dilution, 1:50; Santa Cruz Biotechnology) (Wang et al., 2007) . Sections were counterstained with Meyer's hematoxylin. Negative controls with normal rabbit serum were processed in parallel and no positive staining was observed.
